Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Mar;14(3):180–184. doi: 10.1007/BF00205357

Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas

Istvan Berczi 1,✉, Valerie Holford-Strevens 1, Zamir H Warsi 1, Laurence S McMorris 2, Robert H Thorlakson 3, Thorburn K Thorlakson 3, Alec H Sehon 1
PMCID: PMC11040939  PMID: 6551192

Abstract

A total of 208 plasma samples from 115 patients with gastrointestinal carcinomas and nine patients with other intestinal disease were examined for the presence of IgE tumor antibodies by a solid-phase radioimmunoassay. Approximately one-third of the patients gave significant reactions with gastrointestinal carcinoma extracts compared with normal tissue extracts. Absorption with tumor and normal tissue extracts, with type AB human red cells, and with CEA indicated tumor specificity in some of the samples so examined. None of the 50 serum samples tested from normal blood donors contained tumor-specific IgE. IgE tumor antibodies decreased or completely disappeared in the majority of patients 8–13 days after surgical treatment.

Keywords: Carcinoma, Cancer Research, Serum Sample, Plasma Sample, Blood Donor

References

  • 1.Bartholomaeus WN, Keast D. Reaginic antibody to tumor and alloantigens in mice. Nature. 1972;239:206. doi: 10.1038/newbio239206a0. [DOI] [PubMed] [Google Scholar]
  • 2.Berczi I, McMorris LS, Thorlakson TK, Thorlakson RH, Sehon AH. Detection of tumor antibodies in patients with gastrointestinal carcinomas by a solid-phase radioimmunoassay. J Natl Cancer Inst. 1979;63:553. doi: 10.1093/jnci/63.3.553. [DOI] [PubMed] [Google Scholar]
  • 3.Bowen JG, Baldwin RW. Tumor-specific antigen related to rat histocompatibility antigens. Nature. 1975;258:75. doi: 10.1038/258075a0. [DOI] [PubMed] [Google Scholar]
  • 4.Broom BC, Alexander P. Rat tumor allografts evoke anaphylactic antibody responses. Immunology. 1975;28:1033. [PMC free article] [PubMed] [Google Scholar]
  • 5.Burtin C, Scheinmann P, Salomon JC, Lespinats G, Frayssinet C, Lebel B, Canu P. Increased tissue histamine in tumour-bearing mice and rats. Br J Cancer. 1981;43:684. doi: 10.1038/bjc.1981.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Campbell DH, Garvey FS, Cremer NE, Sussdorf DH. Methods in immunology. 2nd edn. New York: W. A. Benjamin; 1970. [Google Scholar]
  • 7.Ceska M, Erickson R, Varga JM. Radioimmunosorbent assay of allergens. J Allergy Clin Immunol. 1972;49:1. doi: 10.1016/0091-6749(72)90117-0. [DOI] [PubMed] [Google Scholar]
  • 8.Coligan JE, Lantenschleger JT, Egan ML, Todd CW. Isolation and characterization of carinoembryonic antigen. Immunochemistry. 1972;9:377. doi: 10.1016/0019-2791(72)90308-4. [DOI] [PubMed] [Google Scholar]
  • 9.Costanza ME, Pinn V, Schwartz RS, Nathanson L. Carcinoembryonic antigen-antibody complexes and nephrotic syndrome. N Engl J Med. 1973;289:520. doi: 10.1056/NEJM197309062891007. [DOI] [PubMed] [Google Scholar]
  • 10.Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ. Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinomata. Am J Med. 1974;57:962. doi: 10.1016/0002-9343(74)90176-4. [DOI] [PubMed] [Google Scholar]
  • 11.Denk H, Tappiner G, Holzner HJ. Blood group substances (BG) as carcinofetal antigens in carcinomas of the distal colon. Eur J Cancer. 1974;10:487. doi: 10.1016/0014-2964(74)90071-1. [DOI] [PubMed] [Google Scholar]
  • 12.Feizi T, Turberville C, Westwood JH. Blood-group precursors and cancer-related antigens. Lancet. 1975;II:391. doi: 10.1016/s0140-6736(75)92899-8. [DOI] [PubMed] [Google Scholar]
  • 13.Fujimoto S, Chen CH, Sabbadini E, Sehon AH. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice. J Immunol. 1973;111:1093. [PubMed] [Google Scholar]
  • 14.Gold JM, Gold P. The blood group A-like site on the carcinoembryonic antigen. Cancer Res. 1973;33:2821. [PubMed] [Google Scholar]
  • 15.Hewetson JF, Gothoskar B, Klein G. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus. J Natl Cancer Inst. 1972;48:87. [PubMed] [Google Scholar]
  • 16.Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962;194:495. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  • 17.Invernizzi G, Parmiani G. Tumor-associated transplantation antigens of chemically induced sarcomata crossreacting with allogeneic histocompatibility antigens. Nature. 1975;254:713. doi: 10.1038/254713a0. [DOI] [PubMed] [Google Scholar]
  • 18.Kapsopoulou-Dominos K, Anderer FA. Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract. Clin Exp Immunol. 1979;35:190. [PMC free article] [PubMed] [Google Scholar]
  • 19.Lynch NR, Salomon JC. Tumour-associated inhibition of immediate hypersensitivity reaction in mice. Immunology. 1977;32:645. [PMC free article] [PubMed] [Google Scholar]
  • 20.Lynch NR, Salomon J-C, Turner KJ. Evolutionary development of IgE and the role of anaphylactic-type reactions in resistance to solid tumors. Cancer Immunol Immunother. 1978;4:223. [Google Scholar]
  • 21.Mavligit GM, Calvo DB, III, Patt YZ, Hersh EM. Immune restoration and/or augmentation of local xenogeneic graft versus host reaction by Cimetidine in vitro. J Immunol. 1981;126:2272. [PubMed] [Google Scholar]
  • 22.Meltzer MS, Leonard EJ, Rapp HJ, Borsos T. Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst. 1971;47:703. [PubMed] [Google Scholar]
  • 23.Mendenhall W. Introduction to probability and statistics. 3rd edn. Belmont: Duxbury Press; 1967. p. 223. [Google Scholar]
  • 24.Osband ME, Hamilton D, Shen Y-J, Cohen E, Slesinger M, Lavin P, Brown A, McCaffrey R. Successful tumour immunotherapy with cimetidine in mice. Lancet. 1981;I:636. doi: 10.1016/s0140-6736(81)91554-3. [DOI] [PubMed] [Google Scholar]
  • 25.Parmiani G, Meschini A, Ballinari D. Original H-2d and foreign H-2k-like antigens are independent entities on a chemically induced sarcoma. J Immunogenet. 1978;5:297. doi: 10.1111/j.1744-313x.1978.tb00658.x. [DOI] [PubMed] [Google Scholar]
  • 26.Reisfeld RA, Pellegrino MA, Kahan DB. Salt extraction of soluble HL-A antigens. Science. 1971;172:1134. doi: 10.1126/science.172.3988.1134. [DOI] [PubMed] [Google Scholar]
  • 27.Rosenbaum JZ, Dwyer JM. Role of IgE in immune response to neoplasia. Review. Cancer. 1977;39:11. doi: 10.1002/1097-0142(197701)39:1<11::aid-cncr2820390104>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  • 28.Springer GF, Desai PR, Scanlon EF. Blood group MN precursors as human breast carcinoma-associated antigens and naturally occurring human cytotoxins against them. Cancer. 1976;37:169. doi: 10.1002/1097-0142(197601)37:1<169::aid-cncr2820370124>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  • 29.Sweeney WT, Seibel HR. Histamine release from peritoneal mast cells of tumor susceptible rats following periods of tumor growth and sensitization with tumor antigen and B. pertussis . Int Arch Allergy. 1973;45:789. doi: 10.1159/000231078. [DOI] [PubMed] [Google Scholar]
  • 30.Watanabe K, Hakamori SI. Status of blood group carbohydrate chains in ontogenesis and in oncogenesis. J Exp Med. 1976;144:644. doi: 10.1084/jem.144.3.644. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES